Identification of drug-target interaction from interactome network with 'guilt-by-association' principle and topology features.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 26614126.
- Also identified by DOI 10.1093/bioinformatics/btv695.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Identifying drug-target protein interaction is a crucial step in the process of drug research and development. Wet-lab experiment are laborious, time-consuming and expensive. Hence, there is a strong demand for the development of a novel theoretical method to identify potential interaction between drug and target protein. We use all known proteins and drugs to construct a nodes- and edges-weighted biological relevant interactome network. On the basis of the 'guilt-by-association' principle, novel network topology features are proposed to characterize interaction pairs and random forest algorithm is employed to identify potential drug-protein interaction. Accuracy of 92.53% derived from the 10-fold cross-validation is about 10% higher than that of the existing method. We identify 2272 potential drug-target interactions, some of which are associated with diseases, such as Torg-Winchester syndrome and rhabdomyosarcoma. The proposed method can not only accurately predict the interaction between drug molecule and target protein, but also help disease treatment and drug discovery. zhanchao8052@gmail.com or ceszxy@mail.sysu.edu.cn Supplementary data are available at Bioinformatics online.
Medical subject headings
- Drug Delivery Systems
- Drug Discovery
- Protein Interaction Maps